canrenoic acid has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eguchi, A; Hayashi, SM; Inohana, M; Kawashima, M; Koyanagi, M; Maronpot, RR; Mizukami, S; Murayama, H; Nagahara, R; Nakamura, M; Shibutani, M; Yoshida, T | 1 |
1 other study(ies) available for canrenoic acid and Liver Neoplasms
Article | Year |
---|---|
Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats.
Topics: Animals; Antioxidants; Canrenoic Acid; Catalase; Diet, High-Fat; Disease Models, Animal; Gene Expression; Glutathione S-Transferase pi; Kidney; Liver; Liver Neoplasms; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Organ Specificity; Quercetin; Receptors, Mineralocorticoid; Signal Transduction | 2018 |